RopesTalk

On this episode of Ropes & Gray’s podcast series Controlling Opinions, Josh Oyster, a partner in the life sciences regulatory and compliance practice group, is joined by colleagues Andrew O’Connor, a litigation and enforcement partner, and Beth Weinman, life sciences regulatory and compliance counsel. Together, they delve into the complexities of DEA diversion investigations and how health care entities can prepare for these challenging situations. They discuss the risks involved, the various players in these investigations, and the enforcement consequences that can result. They also provide practical advice on navigating DEA audits and share insights from recent enforcement matters. 

Katie Daniels, the Managing Director and Head of Compliance at CPP Investments, shares her innovative journey using behavioral science to tackle compliance challenges. She emphasizes the human factor in compliance and how authenticity and vulnerability can strengthen trust. Listeners can learn about impactful compliance interventions, the importance of organizational culture, and the need for open communication. Plus, Katie reveals her love for live music and theater, adding a creative twist to compliance discussions!

On this episode of Women @ RopesTalk hosted by health care and data partner Christine Moundas, litigation & enforcement partner Sarah Walters is joined by Veronica Lei, the associate vice president and assistant general counsel for Eli Lilly's Diabetes Alliance. Veronica shares her diverse career journey from being a federal prosecutor to her current role at Eli Lilly, discussing her experiences in litigation, internal investigations and business counseling. She also reflects on the importance of balancing professional and personal life and offers valuable advice for aspiring legal professionals.

On this episode of Ropes & Gray’s Health Care Transaction Laws Unwrapped podcast series, health care attorneys Christina Bergeron and Natalie LaRue discuss recent developments in state health care transaction laws and their impacts on private equity investments in health care. With an increase in transaction laws specifically targeting private equity, including passed legislation in Indiana and bills that were considered in California, Massachusetts, Connecticut and Minnesota, they discuss the effects these laws have on the dealmaking landscape and key takeaways for these investors.

On this episode of Ropes & Gray’s California Law for Asset Managers podcast series, asset management partner Catherine Skulan and employment partners Greg Demers, Richard Kidd and associate Patrick Maher, discuss recent developments in California employment law that may impact asset managers and their portfolio companies. The group will address a new California noncompete statute, including a recent case that gives some insight into the contours of the law, and new California requirements to implement comprehensive workplace violence prevention plans. 

On this fourth episode of Ropes & Gray’s Health Care Transaction Laws Unwrapped podcast series, health care attorneys Ranee Adipat, Jenn Romig and Jaclyn Freshman discuss the latest updates to state health care transaction laws on the West Coast. The team explores recent developments in California and Oregon, including California's AB 3129 (recently vetoed by Governor Newsom) and Oregon's proactive enforcement. The episode offers practical advice on navigating these complex regulatory environments, the impact on deal timelines, and strategic considerations for health care entities and private equity investors. 

On this episode of Ropes & Gray’s podcast series, Non-binding Guidance, life sciences regulatory and compliance partner Greg Levine and counsel Beth Weinman are joined by appellate and Supreme Court practice head Doug Hallward-Driemeier to explore the Supreme Court's recent landmark decision in Loper Bright, which ended the long-standing practice of Chevron deference. Learn how this ruling has reshaped the regulatory landscape for federal agencies like the FDA and what it means for companies navigating these changes, including implications for Administrative Procedure Act (APA) challenges going forward. 

Dr. Brennan Jacoby, a philosopher and founder of Philosophy at Work, chats about weaving ethics into organizational culture from his global travels. He highlights the philosophy of trust and how compliance teams can nurture it. Listeners learn about his Ethics Lab workshops that empower meaningful ethical discussions. The conversation dives into the significance of critical thinking, empathy, and communication in navigating ethical dilemmas. Jacoby provides practical exercises for teams to enhance their engagement and foster a culture of trust.

On this episode of the R&G Tech Studio podcast, host Brad Flint, co-leader of Ropes & Gray’s venture capital and emerging companies practice, is joined by Raj Banerjee, a partner in both the venture capital and emerging companies practice, as well as the IP transactions group at Ropes & Gray. Raj shares insights from his extensive experience as a life sciences lawyer, focusing on the intersection of AI and life sciences. He discusses the significant trends in AI investment, the impact of AI on corporate America, and how these developments are reshaping the venture investing world. Raj also highlights the role Ropes & Gray plays in helping clients navigate these exciting changes, from structuring licensing deals to providing specialized regulatory advice. 

On this third episode of Ropes & Gray’s Health Care Transaction Laws Unwrapped podcast series, health care attorneys Brett Friedman, Ben Wilson and Sharon Jaquez discuss the latest updates to state health care transaction laws on the East Coast. The team explores recent developments in New York, Massachusetts, Connecticut and Pennsylvania, examining the implications of new and pending legislation on health care transactions. They provide practical insights on navigating the evolving regulatory landscape, the impact on deal timelines, confidentiality, and strategic considerations for health care entities and private equity investors.